NCT00194402View on ClinicalTrials.gov

SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Dyslipidemia
Interventions
DRUG

Slo-Niacin, atorvastatin

Atorvastatin 10 mg qd for 12 or 24 weeks. Time-released niacin 1500 mg qd (titrated from 500mg to 1000mg and then to 1500 mg at 4 week intervals) taken for 12 or 24 weeks.

Trial Locations (1)

98104

Northwest Lipid Research Clinic, University of Washington, Seattle

All Listed Sponsors
collaborator

Upsher-Smith Laboratories

INDUSTRY

lead

University of Washington

OTHER

NCT00194402 - SLIM: Combined Effects of Slo-Niacin and Atorvastatin on Lipoproteins and Inflammatory Markers in Hyperlipidemia | Biotech Hunter | Biotech Hunter